egfr-targeted therapy in metastatic colorectal cancer
Published 6 years ago • 552 plays • Length 7:42Download video MP4
Download video MP3
Similar videos
-
7:10
upfront egfr therapy in metastatic colorectal cancer
-
1:12
targeted therapies in metastatic colorectal cancer
-
5:09
egfr therapy as upfront colorectal cancer treatment
-
13:46
choosing between vegf and egfr targeted therapy in mcrc
-
13:46
choosing between anti-vegf and anti-egfr targeted therapy
-
0:54
targeted therapies in colorectal cancer
-
7:32
considerations when selecting an egfr inhibitor in metastatic colorectal cancer
-
1:33
acquired resistance to anti-egfr therapy in colorectal cancer
-
1:30
overcoming acquired resistance to targeted therapy in colorectal cancer
-
4:00
optimizing treatment with egfr inhibitors in colorectal cancer
-
1:31
targeted therapies showing promise in colorectal cancer
-
16:56
colorectal cancer with acquired resistance to egfr antibodies: how to manage?
-
4:56
upfront bevacizumab and cetuximab compared in metastatic colorectal cancer
-
6:19
clinical development of cetuximab in metastatic colorectal cancer
-
4:15
egfr in metastatic colon cancer
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
1:28
dr. mizrahi on targeting treatment in metastatic colorectal cancer
-
4:33
first-line targeted therapies in metastatic crc
-
41:23
multimodal management of early-stage nsclc: egfr-targeted therapy in perioperative settings